• Explore /
  • Poster
  • / Phase I study of hepatic arterial infusion (HAI) therapy with floxuridine (FUDR) combined with systemic gemcitabine and oxaliplatin in patients with locally advanced intrahepatic cholangiocarcinoma (ICC).

Phase I study of hepatic arterial infusion (HAI) therapy with floxuridine (FUDR) combined with systemic gemcitabine and oxaliplatin in patients with locally advanced intrahepatic cholangiocarcinoma (ICC).

Abstract Poster

Authors

null

Patrick Grierson

Washington University in St. Louis, St. Louis, MO

Patrick Grierson , Aabha Oza , Maria Majella Doyle , Kathryn Fowler , Ryan Fields , William G. Hawkins , Chet Hammill , Andrea Wang-Gillam , Manik A. Amin , Katrina Pedersen , Kian-Huat Lim , Ashley Morton , Christine Cordova , Benjamin R. Tan Jr., William C. Chapman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01525069

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 417)

DOI

10.1200/JCO.2018.36.4_suppl.417

Abstract #

417

Poster Bd #

K10

Abstract Disclosures

Similar Posters

First Author: Andrea Cercek

First Author: Jonathan Matthew Hernandez

First Author: Brett S Walker

First Author: Lyudmyla Derby Berim